| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Nov 7, 2025 | Nov 12, 2025 | Spero Therapeutics, Inc. | Officer | Sell | 42.5 | -40,270 | -4.43% | ✗ | $95.4K |
| Feb 3, 2025 | Feb 5, 2025 | Spero Therapeutics, Inc. | CFO | Sell | 91.3 | +345,450 | 91.08% | ✗ | $16.1K |
| Nov 7, 2024 | Nov 12, 2024 | Spero Therapeutics, Inc. | CFO | Sell | 42.5 | -40,596 | -9.67% | ✗ | $53K |